SEC Filings for Ligand Pharmaceuticals Incorporated (LGND)

$ 66.79   -6.13 (-8.41%) Volume: 745.86k 4:00 PM EDT 27-Mar-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
4Statement of changes in beneficial ownership of securities103/13/2020
4Statement of changes in beneficial ownership of securities102/27/2020
10-KAnnual report pursuant to Section 13 or 15(d)19102/27/2020
4Statement of changes in beneficial ownership of securities102/18/2020
4Statement of changes in beneficial ownership of securities102/18/2020
4Statement of changes in beneficial ownership of securities102/18/2020
4Statement of changes in beneficial ownership of securities102/18/2020
SC 13GStatement of acquisition of beneficial ownership by individuals702/14/2020
SC 13GStatement of acquisition of beneficial ownership by individuals102/14/2020
3Initial statement of beneficial ownership of securities102/14/2020
SC 13GStatement of acquisition of beneficial ownership by individuals102/14/2020
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals102/13/2020
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals502/12/2020
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals502/12/2020
8-KCurrent report pursuant to Section 13 or 15(d)802/11/2020
<<
First
<
Prev
123456789101112131415